CryoPort Price to Sales Ratio 2010-2023 | CYRX
Historical PS ratio values for CryoPort (CYRX) over the last 10 years. The current P/S ratio for CryoPort as of May 01, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| CryoPort P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-05-02 |
17.16 |
|
3.58 |
| 2023-12-31 |
15.49 |
$4.79 |
3.23 |
| 2023-09-30 |
13.71 |
$4.85 |
2.83 |
| 2023-06-30 |
17.25 |
$4.95 |
3.49 |
| 2023-03-31 |
24.00 |
$5.09 |
4.71 |
| 2022-12-31 |
17.35 |
$4.85 |
3.58 |
| 2022-09-30 |
24.36 |
$4.84 |
5.03 |
| 2022-06-30 |
30.98 |
$4.83 |
6.42 |
| 2022-03-31 |
34.91 |
$4.74 |
7.37 |
| 2021-12-31 |
59.17 |
$4.90 |
12.07 |
| 2021-09-30 |
66.51 |
$4.93 |
13.50 |
| 2021-06-30 |
63.10 |
$3.98 |
15.84 |
| 2021-03-31 |
52.01 |
$3.00 |
17.33 |
| 2020-12-31 |
43.88 |
$2.04 |
21.46 |
| 2020-09-30 |
47.40 |
$1.07 |
44.39 |
| 2020-06-30 |
30.25 |
$1.05 |
28.78 |
| 2020-03-31 |
17.07 |
$1.08 |
15.85 |
| 2019-12-31 |
16.46 |
$1.04 |
15.90 |
| 2019-09-30 |
16.36 |
$0.96 |
17.03 |
| 2019-06-30 |
18.32 |
$0.88 |
20.93 |
| 2019-03-31 |
12.92 |
$0.77 |
16.77 |
| 2018-12-31 |
11.03 |
$0.70 |
15.71 |
| 2018-09-30 |
12.81 |
$0.65 |
19.86 |
| 2018-06-30 |
15.78 |
$0.58 |
27.06 |
| 2018-03-31 |
8.60 |
$0.54 |
15.97 |
| 2017-12-31 |
8.59 |
$0.54 |
15.84 |
| 2017-09-30 |
9.85 |
$0.55 |
17.77 |
| 2017-06-30 |
4.92 |
$0.56 |
8.73 |
| 2017-03-31 |
2.36 |
$0.58 |
4.09 |
| 2016-12-31 |
3.24 |
$0.57 |
5.69 |
| 2016-09-30 |
1.97 |
$0.61 |
3.21 |
| 2016-06-30 |
2.08 |
$0.70 |
2.95 |
| Sector |
Industry |
Market Cap |
Revenue |
| Transportation |
Transportation - Services |
$0.826B |
$0.233B |
|
CryoPort, Inc. operates as a provider of shipping solutions comprising cold chain frozen shipping system for transporting biological, environmental and other temperature sensitive materials at temperatures below minus 150? Celsius. Its products include CryoPort Express Shippers, cryogenic dry vapor shippers capable of maintaining cryogenic temperatures; biological material holders for the shipment of infectious or dangerous goods; CryoPort Express System to programmatically manage order entry and various aspects of shipping operations; and CryoPort Express Analytics, to monitor shipment performance metrics and to evaluate temperature-monitoring data collected by the data logger during shipment. The Company's products find their application in the transportation of live cell pharmaceutical products, such as cancer vaccines, diagnostic materials, semen and embryos, and infectious substances. CryoPort, Inc. is based in Lake Forest, California.
|
